John Overdeck’s Fennec Pharmaceuticals FENC Stock Holding History

John Overdeck’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$649K	Buy	+60,332	New	+$493K	﹤0.01%	3950
2023 Q3	–	Sell	-13,561	Closed	-$120K	–	3030
2023 Q2	$120K	Sell	13,561 -46,809	-78%	-$389K	﹤0.01%	2730
2023 Q1	$502K	Sell	60,370 -27,301	-31%	-$253K	﹤0.01%	2200
2022 Q4	$842K	Buy	+87,671	New	+$776K	﹤0.01%	1783
2020 Q3	–	Sell	-13,828	Closed	-$115K	–	3235
2020 Q2	$115K	Buy	+13,828	New	+$103K	﹤0.01%	2770

Other funds holding FENC

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCA

Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

John Overdeck's FENC Position: Q2 2026 in Review

John Overdeck opened a new position in Fennec Pharmaceuticals (FENC) in Q2 2026: 60,332 shares worth $649K. The stake represents ﹤0.01% of the portfolio and ranks #3950 among its holdings. This is a return to the name: John Overdeck previously reported a position in FENC as recently as Q2 2023.

John Overdeck first reported a position in FENC in Q2 2020 and has held it in 5 quarters since. The position peaked at $842K in Q4 2022. 104 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

John Overdeck held 60,332 shares of Fennec Pharmaceuticals worth $649K as of Q2 2026.
Fennec Pharmaceuticals was a new John Overdeck position in Q2 2026.
Fennec Pharmaceuticals made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3950 holding.
John Overdeck first reported a position in Fennec Pharmaceuticals in Q2 2020 and has held it in 5 quarters since.
John Overdeck's Fennec Pharmaceuticals position peaked at $842K in Q4 2022.
104 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.